“Gender and Clinical Trials: Is the Regulation N. 536 2914 (EU) a Missed Opportunity?”. 2022. TEST BioLaw Journal - Rivista Di BioDiritto, no. 4 (December): 251-76. https://doi.org/10.15168/2284-4503-2478.